|
Market Closed -
Bombay S.E.
18:02:23 23/09/2026 HKT
|
5-day change | 1st Jan Change | ||
| 572.95 INR | +7.16% |
|
+9.30% | +29.82% |
| Market Cap | 40.34B 421M 370M 347M 318M 594M 598M 4.17B 1.62B 20.57B 1.58B 1.55B 66.68B | P/E 2025 |
35.6x | P/E 2026 | 8.19x |
|---|---|---|---|---|---|
| Enterprise Value | 42.45B 443M 389M 366M 334M 625M 629M 4.39B 1.7B 21.64B 1.66B 1.63B 70.16B | EV / Sales 2025 |
2.49x | EV / Sales 2026 | 1.03x |
| Free-Float |
28.74% | Yield 2025 * |
-
| Yield 2026 | - |
Bombay S.E.INR
| Markets | Quality | ||
|---|---|---|---|
Bombay S.E.
| UNICHEMLAB | Delayed | |
NSE India S.E.
| UNICHEMLAB | Delayed |
| 1 day | +7.16% | ||
| 1 week | +9.30% | ||
| Current month | +3.00% | ||
| 1 month | +8.97% | ||
| 3 months | +31.41% | ||
| 6 months | +90.35% | ||
| Current year | +29.82% |
| 1 week | 519.8 |  | 576.2 |
| 1 month | 499.25 | | 590 |
| Current year | 280 | | 685.95 |
| 1 year | 280 | | 685.95 |
| 3 years | 280 | | 949.85 |
| 5 years | 197.5 | | 949.85 |
| 10 years | 75.1 | | 949.85 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 10/08/2023 | |
Sanjay Jain
DFI | Director of Finance/CFO | - | 08/08/2024 |
Dhananjay Sathe
CMP | Compliance Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 22/08/1977 | |
Pranay Godha
BRD | Director/Board Member | 53 | 10/08/2023 |
| Director/Board Member | 57 | 10/08/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +7.16% | +9.30% | +15.96% | +37.53% | 394M | |
| -1.64% | +1.16% | +54.09% | +109.07% | 1,043B | |
| -0.01% | +0.71% | +52.44% | +67.71% | 649B | |
| -0.05% | +0.98% | +19.08% | +73.55% | 469B | |
| -0.25% | +0.19% | +36.95% | +45.63% | 355B | |
| +0.98% | +2.91% | +20.59% | +27.91% | 270B | |
| -1.91% | +2.42% | +10.41% | +12.53% | 262B | |
| -1.01% | +7.90% | +41.59% | +51.70% | 222B | |
| -0.85% | +2.50% | +32.32% | +101.80% | 189B | |
| -2.53% | -7.47% | -32.63% | -60.67% | 175B | |
| Average | +0.50% | +1.54% | +25.08% | +46.67% | 363.34B | |
| Weighted average by Cap. | +0.44% | +1.34% | +35.88% | +65.85% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 21.11B 220M 193M 182M 166M 311M 313M 2.18B 847M 10.76B 828M 809M 34.89B | 22.02B 230M 202M 190M 173M 324M 326M 2.28B 883M 11.23B 863M 844M 36.4B |
| Net income | 1.38B 14.36M 12.6M 11.84M 10.83M 20.24M 20.39M 142M 55.15M 701M 53.91M 52.73M 2.27B | 2.53B 26.39M 23.17M 21.78M 19.91M 37.2M 37.48M 262M 101M 1.29B 99.12M 96.95M 4.18B |
| Net Debt | 3.7B 38.65M 33.92M 31.88M 29.15M 54.47M 54.88M 383M 148M 1.89B 145M 142M 6.12B | 2.11B 21.99M 19.3M 18.14M 16.59M 31M 31.23M 218M 84.49M 1.07B 82.59M 80.78M 3.48B |
Employees
2,780
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/09/26 | ₹572.95 | +7.16% | 14,957 |
| 22/09/26 | ₹534.65 | -0.92% | 6,968 |
| 21/09/26 | ₹539.60 | -1.08% | 4,298 |
| 18/09/26 | ₹545.50 | +1.46% | 2,944 |
| 17/09/26 | ₹537.65 | +2.57% | 4,907 |
- Stock Market
- Stocks
- UNICHEMLAB Stock
Select your edition
All financial news and data tailored to specific country editions
